EPA-话题@MedSci

#EPA#

1120篇内容 | 2796人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1427534, encodeId=f508142e5346e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=NEJM：Tirzepatide头对头III期研究成功降糖减重效果优于索马鲁肽, objectType=article, longId=213588, objectId=8938213588ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8938213588ec, replyNumber=0, likeNumber=70, createdTime=2021-07-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8938213588ec, moduleTitle=NEJM：Tirzepatide头对头III期研究成功降糖减重效果优于索马鲁肽, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8938213588ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427533, encodeId=4952142e53346, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效, objectType=article, longId=213475, objectId=ae672134e56d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae672134e56d, replyNumber=0, likeNumber=54, createdTime=2021-06-30, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae672134e56d, moduleTitle=Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae672134e56d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427532, encodeId=4bc2142e5328d, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatol Int:晚期黑色素瘤患者中免疫检查点抑制剂介导的肝炎与肝转移和临床预后的关系, objectType=article, longId=213469, objectId=74a52134694c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74a52134694c, replyNumber=0, likeNumber=65, createdTime=2021-06-30, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74a52134694c, moduleTitle=Hepatol Int:晚期黑色素瘤患者中免疫检查点抑制剂介导的肝炎与肝转移和临床预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74a52134694c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427531, encodeId=61e7142e5316f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=NEJM:2型糖尿病治疗，Tirzepatide 优于索马鲁肽！, objectType=article, longId=213385, objectId=bfd921338507, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfd921338507, replyNumber=0, likeNumber=74, createdTime=2021-06-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfd921338507, moduleTitle=NEJM:2型糖尿病治疗，Tirzepatide 优于索马鲁肽！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfd921338507)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427530, encodeId=e21f142e530ce, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle= Hepatology：在非洲发现丙型肝炎新菌株, objectType=article, longId=213200, objectId=9e732132005d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e732132005d, replyNumber=0, likeNumber=66, createdTime=2021-06-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e732132005d, moduleTitle= Hepatology：在非洲发现丙型肝炎新菌株, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e732132005d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427529, encodeId=2652142e52914, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：目前和既往乙肝感染不增加COVID-19患者的死亡率, objectType=article, longId=213089, objectId=66be2130897c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66be2130897c, replyNumber=0, likeNumber=85, createdTime=2021-06-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66be2130897c, moduleTitle=Hepatology：目前和既往乙肝感染不增加COVID-19患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66be2130897c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427528, encodeId=eca4142e528b6, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：肝内胆管癌和肝细胞癌的临床特征和预后差异！, objectType=article, longId=212789, objectId=f7f1212e899d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7f1212e899d, replyNumber=0, likeNumber=164, createdTime=2021-06-17, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7f1212e899d, moduleTitle=Hepatology：肝内胆管癌和肝细胞癌的临床特征和预后差异！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7f1212e899d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427527, encodeId=e900142e52755, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：辅助放疗可有效巩固肝癌窄切缘肝切除术的疗效, objectType=article, longId=212569, objectId=a3b92125691a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3b92125691a, replyNumber=0, likeNumber=116, createdTime=2021-06-12, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3b92125691a, moduleTitle=Hepatology：辅助放疗可有效巩固肝癌窄切缘肝切除术的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3b92125691a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427526, encodeId=73f4142e526f4, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology: 胆红素和碱性磷酸酶升高与药物性肝损伤的恢复时间延长有关, objectType=article, longId=212308, objectId=0389212308c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0389212308c8, replyNumber=0, likeNumber=82, createdTime=2021-06-06, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0389212308c8, moduleTitle=J Hepatology: 胆红素和碱性磷酸酶升高与药物性肝损伤的恢复时间延长有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0389212308c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427525, encodeId=5b02142e5250a, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology：索拉非尼能降低肝细胞癌的肿瘤生长速度降低和肝功能的恶化, objectType=article, longId=212307, objectId=6a7721230e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a7721230e0e, replyNumber=0, likeNumber=77, createdTime=2021-06-06, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a7721230e0e, moduleTitle=J Hepatology：索拉非尼能降低肝细胞癌的肿瘤生长速度降低和肝功能的恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a7721230e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427524, encodeId=23b8142e524ad, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实, objectType=article, longId=211942, objectId=78d22119421d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d22119421d, replyNumber=0, likeNumber=68, createdTime=2021-05-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d22119421d, moduleTitle=OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d22119421d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427523, encodeId=059e142e523dd, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology:慢性肝病和肝移植患者体外受精的安全性和有效性分析, objectType=article, longId=211742, objectId=92e4211e4282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92e4211e4282, replyNumber=0, likeNumber=69, createdTime=2021-05-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92e4211e4282, moduleTitle=J Hepatology:慢性肝病和肝移植患者体外受精的安全性和有效性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92e4211e4282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427522, encodeId=7247142e522a5, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology：新冠肺炎患者肝脏异常与住院死亡率的关系, objectType=article, longId=211741, objectId=4110211e4195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4110211e4195, replyNumber=0, likeNumber=70, createdTime=2021-05-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4110211e4195, moduleTitle=J Hepatology：新冠肺炎患者肝脏异常与住院死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4110211e4195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427521, encodeId=6f79142e52186, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology:质子泵抑制剂（PPI）的长期服用能够增加胆道癌的发病率：来自瑞典人群队列研究结果, objectType=article, longId=211693, objectId=a25c211693a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a25c211693a6, replyNumber=0, likeNumber=68, createdTime=2021-05-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a25c211693a6, moduleTitle=Hepatology:质子泵抑制剂（PPI）的长期服用能够增加胆道癌的发病率：来自瑞典人群队列研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a25c211693a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427520, encodeId=1f08142e520b0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatol Int：安罗替尼（Anlotinib）治疗晚期肝细胞癌（HCC）的疗效和安全性：来自ALTER‑0802研究结果, objectType=article, longId=211682, objectId=d50921168225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d50921168225, replyNumber=0, likeNumber=66, createdTime=2021-05-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d50921168225, moduleTitle=Hepatol Int：安罗替尼（Anlotinib）治疗晚期肝细胞癌（HCC）的疗效和安全性：来自ALTER‑0802研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d50921168225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427519, encodeId=7568142e519a8, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：控制血糖可降低非酒精性脂肪肝肝纤维化风险, objectType=article, longId=211576, objectId=5e012115e64b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e012115e64b, replyNumber=0, likeNumber=135, createdTime=2021-05-22, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e012115e64b, moduleTitle=Hepatology：控制血糖可降低非酒精性脂肪肝肝纤维化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e012115e64b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427518, encodeId=f388142e51838, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterol Hepatol: COVID-19住院期间严重肝损伤与肝功能不全或死亡无关, objectType=article, longId=211556, objectId=fe052115561d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe052115561d, replyNumber=0, likeNumber=95, createdTime=2021-05-21, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe052115561d, moduleTitle=Clin Gastroenterol Hepatol: COVID-19住院期间严重肝损伤与肝功能不全或死亡无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe052115561d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427517, encodeId=b555142e517f8, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, objectType=article, longId=211429, objectId=be23211429df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be23211429df, replyNumber=0, likeNumber=67, createdTime=2021-05-18, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be23211429df, moduleTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be23211429df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427516, encodeId=f9a9142e516e4, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology: 肝脏手术围手术期接受血清素再摄取抑制剂治疗的后果, objectType=article, longId=211428, objectId=68702114286d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68702114286d, replyNumber=0, likeNumber=119, createdTime=2021-05-18, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68702114286d, moduleTitle=J Hepatology: 肝脏手术围手术期接受血清素再摄取抑制剂治疗的后果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68702114286d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427515, encodeId=84d4142e51545, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：磁共振成像和超声对胆汁性胆管炎患者的早期胆管癌的预测作用, objectType=article, longId=211427, objectId=580f21142ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=580f21142ea7, replyNumber=0, likeNumber=101, createdTime=2021-05-18, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=580f21142ea7, moduleTitle=Hepatology：磁共振成像和超声对胆汁性胆管炎患者的早期胆管癌的预测作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=580f21142ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EPA

2020-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

NEJM：Tirzepatide头对头III期研究成功降糖减重效果优于索马鲁肽

2021-07-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效

2021-06-30

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatol Int:晚期黑色素瘤患者中免疫检查点抑制剂介导的肝炎与肝转移和临床预后的关系

2021-06-30

gwc384 (审核中...)

前往app查看评论内容

#EPA#

NEJM:2型糖尿病治疗，Tirzepatide 优于索马鲁肽！

2021-06-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：在非洲发现丙型肝炎新菌株

2021-06-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：目前和既往乙肝感染不增加COVID-19患者的死亡率

2021-06-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：肝内胆管癌和肝细胞癌的临床特征和预后差异！

2021-06-17

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：辅助放疗可有效巩固肝癌窄切缘肝切除术的疗效

2021-06-12

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology: 胆红素和碱性磷酸酶升高与药物性肝损伤的恢复时间延长有关

2021-06-06

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology：索拉非尼能降低肝细胞癌的肿瘤生长速度降低和肝功能的恶化

2021-06-06

gwc384 (审核中...)

前往app查看评论内容

#EPA#

OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实

2021-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology:慢性肝病和肝移植患者体外受精的安全性和有效性分析

2021-05-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology：新冠肺炎患者肝脏异常与住院死亡率的关系

2021-05-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology:质子泵抑制剂（PPI）的长期服用能够增加胆道癌的发病率：来自瑞典人群队列研究结果

2021-05-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatol Int：安罗替尼（Anlotinib）治疗晚期肝细胞癌（HCC）的疗效和安全性：来自ALTER‑0802研究结果

2021-05-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：控制血糖可降低非酒精性脂肪肝肝纤维化风险

2021-05-22

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterol Hepatol: COVID-19住院期间严重肝损伤与肝功能不全或死亡无关

2021-05-21

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关

2021-05-18

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology: 肝脏手术围手术期接受血清素再摄取抑制剂治疗的后果

2021-05-18

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：磁共振成像和超声对胆汁性胆管炎患者的早期胆管癌的预测作用

2021-05-18

科室
- - 订阅+
  - 更多科室
工具
服务